Search results

Selected filters:

Life Sciences
Analysis

Article type

Topic

Sector

Regions

Year

256 results found for your search

Sort options
01 August 2019

Expect Pfizer set to focus on more oncology opportunities following off-patent drug purge

After $12 billion Upjohn deal with Mylan, CEO Bourla says company is on the hunt for early- and mid-stage cancer assets

30 July 2019

Indian messaging app leads hike in domestic patent filings

Annual figures released by the country’s patent office also showed that it rapidly ramped up its ability to process examinations

30 July 2019

Audacious CRISPR interference petition complicates ongoing Cas9 dispute

Sigma-Aldrich seeks to revive its claims to patents reading on the gene technology by inserting itself into the dispute between the Broad and the University of California.

26 July 2019

Australian diagnostic method judgment shows US to be the eligibility outlier

Federal court’s detailed decision emphatically upholds patentability and emphasises, once again, that the Mayo regime is the exception not the rule

24 July 2019

CRISPR patent pool will do little to quash licensing uncertainties

New initiative may help the Broad and MilliporeSigma strike more licensing deals, but is unlikely to heal the deeper fractures in the CRISPR landscape

22 July 2019

Brazilian patent office announces measures to tackle massive backlog

Much greater use of foreign search reports is probably the biggest change - but there are doubts as to how effective the measures will be

20 July 2019

Amgen scores another victory in antibody patent war, but future battles may reverse its fortunes

German court’s injunction against rival PCSK9 inhibitor is not the end of the global dispute, which continues to raise important questions surrounding antibody patenting

19 July 2019

Operating company dominance of the patent deals market continues, latest data reveals

Analysis by AST shows Qualcomm, Samsung and TSMC all active, and volumes in line with recent quarterly averages; software still the leading sector in terms of number of transactions

16 July 2019

Gilead’s unique $5.1 billion licensing deal shows the range of IP monetisation options open to biotech sector

New boss explains that the Big Pharma company will seek out “diverse and creative” asset partnerships – rather than large acquisitions – to boost its pipeline

12 July 2019

Delhi judge orders IP appeal board to start hearing cases again

The body has been paralysed by vacancies for years and more than 600 appeals of patent office decisions are in limbo

11 July 2019

New analysis shows impact that “blockbuster” decisions are having on patent litigation

RPX data highlights big drop in success of early 101 challenges in district court cases; if trend continues would point to shift in balance of power back to IP owners

11 July 2019

CAFC says Congress or SCOTUS must address diagnostics patentability controversy

Decision denying en banc rehearing of much-watched Athena case means that hopes for 101 reform now hinge on legislators and the Supreme Court

08 July 2019

Intel, Alphabet and Qualcomm among big fallers as largest US IP owners cut back on patenting

Latest ranking from IPO of top 300 companies shows an overall decline in the market as the mantra of quality over quantity continues to take effect

05 July 2019

Get ready for the first CRISPR patent pool

In an exclusive interview, MPEG LA’s Kristin Neuman says that a pool is on its way despite the UCal v Broad stand-off and talks about the future of licensing in biotech’s ‘golden age’

03 July 2019

Law firm’s patent attorney deal shows changing face of IP practice in the UK

Lewis Silkin’s acquisition of Ablett & Stebbing is a first and demonstrates just how far things have moved in a once conservative market